| A Rapid Assessment of Road Crashes in Uganda: Notes from the Field AW Walekhwa, F Mulolo, C Achiro, M Nantongo, B Nakazibwe, ... Dr. Sulaiman Al Habib Medical Journal 4 (4), 174-181, 2022 | 4 | 2022 |
| Mycobacterium tuberculosis impairs human memory CD4+ T cell recognition of M2 but not M1-like macrophages DP Gail, VG Suzart, W Du, AK Sandhu, J Jarvela, M Nantongo, I Mwebaza, ... Iscience 26 (9), 2023 | 3 | 2023 |
| Gaps in measles vaccination coverage in Kasese district, Western Uganda: results of a qualitative evaluation AW Walekhwa, D Musoke, A Nalugya, C Biribawa, G Nsereko, ST Wafula, ... BMC Infectious Diseases 22 (1), 589, 2022 | 2 | 2022 |
| Drivers of the Second Wave and clinical characteristics of COVID-19 cases in Uganda: A Retrospective Study of Confirmed SARS-CoV-2 cases AW Walekhwa, B Nakazibwe, M Nantongo, ST Wafula, D Bulafu, ... ResearchSquare, 2022 | 2 | 2022 |
| e-learning as a supplemental teaching tool for secondary students in Uganda: lessons from COVID-19 AW Walekhwa, S Jobanputra, B Nakazibwe, M Nantongo, CD Opio, ... | 1 | 2022 |
| Drivers of the second wave and clinical characteristics of COVID-19 cases in uganda: A retrospective study of confirmed SARS-cov-2 cases, march-june, 2021 AW Walekhwa, B Nakazibwe, M Nantongo, ST Wafula, D Bulafu, B Ayugi, ... | 1 | 2022 |
| Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against Mycobacterium abscessus KM Dousa, E Shin, SG Kurz, M Plummer, M Nantongo, CR Bethel, ... Mbio 15 (6), e00609-24, 2024 | | 2024 |
| Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of Mycobacterium tuberculosis M Nantongo, DC Nguyen, CR Bethel, MA Taracila, Q Li, KM Dousa, ... ACS Infectious Diseases 10 (5), 1767-1779, 2024 | | 2024 |
| 2806. The Mechanism of β-Lactam Antibiotic Action: Structural Analysis of Mycobacterium abscessus l,d-Transpeptidases, d,d-Carboxypeptidase and penicillin … E Shin, M Nantongo, KM Dousa, CR Bethel, MA Taracila, BN Kreiswirth, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2417, 2023 | | 2023 |
| 2565. In vitro synergistic bacterial killing of imipenem and ceftaroline against Mycobacterium abscessus; a static concentration time-kill analysis E Shin, M Nantongo, SM Holland, BN Kreiswirth, KM Dousa, RA bonomo Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2182, 2023 | | 2023 |
| A subgroup of Ugandan elite and viremic controllers naturally control HIV-1 infection by blocking R5-tropic viral entry. A Kayongo, D Semugenze, M Nantongo, F Semitala, AJ Niwaha, ... | | 2020 |
| Molecular Diversity of HIV-1 among Long Term Non-progressors attending MJAP-ISS clinic, Mulago M Nantongo Makerere University, 2018 | | 2018 |
| Mycobacterium tuberculosis Impairs Human Memory CD4 T Cell Recognition of Macrophages Differentiated Using M-CSF But Not GM-CSF D Gail, V Suzart, W Du, AK Sandhu, J Jarvela, M Nantongo, I Mwebaza, ... Impairs Human Memory CD4 T Cell Recognition of Macrophages Differentiated …, 0 | | |
